Supporting healthcare professionals and patients with cannabinoid-based medicines
We believe you and your patients should have the same confidence in our clinically validated cannabinoid-based medicines that you would in any other prescription pharmaceuticals. We’re passionate about contributing to world class science and conducting clinical trials to ensure we continue to deliver an evidence-based range of ethical medicines.
Zelira’s focus is on specific conditions, like chronic insomnia and autism spectrum disorder (ASD), and delivering solutions to patients who are no longer receiving a benefit from their conventional treatments.
Zelira Therapeutics has developed several pharmaceutical-grade cannabinoid-based medicines that are available in Australia and the USA.
This section of the website is reserved for healthcare professionals
To access, please insert your APHRA